Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $11.11 Analyst target: $17.00 Upside: 53.02%
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.